Treatment Patterns and Clinical Outcomes in Elderly Patients with Breast Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Although the number of elderly patients with breast cancer is increasing as the population ages, their treatment is controversial. We evaluated the prognostic factors associated with survival in elderly breast cancer patients and assessed the impact of comorbidity on prognosis. Methods: This study included 362 patients (aged ≥65 years) who underwent surgery for breast cancer in our institution between 2003 and 2014. The patients were divided into early-aged (65–74 years) and late-aged (≥75 years) groups. Comorbidity was parametrized using the Charlson comorbidity index (CCI). Kaplan–Meier analysis was used to analyze overall survival (OS) and distant metastasis-free survival (DMFS). Prognostic factors were evaluated by Cox proportional hazards regression. Results: The surgical method, subtypes, stage, and oncological features were similar between early- and late-aged groups; however, smaller proportions of patients in the late-aged group received chemotherapy (12.9% vs. 45.5%) and endocrine therapy (55.3% vs. 73.3%). In multivariable analysis, the poor prognostic factors associated with DMFS and OS were high CCI, high histologic grade, and advanced stage. Chemotherapy, endocrine therapy, and radiotherapy were not significantly related to DMFS and OS. Conclusion: In this study, adjuvant treatments did not affect the prognosis of elderly patients with breast cancer. To clarify the effects of adjuvant therapies in these patients, a large-scale retrospective study that considers not only tumor characteristics but also life expectancy is necessary.
Abstract
Purpose: Although the number of elderly patients with breast cancer is increasing as the population ages, their treatment is controversial. We evaluated the prognostic factors associated with survival in elderly breast cancer patients and assessed the impact of comorbidity on prognosis. Methods: This study included 362 patients (aged ≥65 years) who underwent surgery for breast cancer in our institution between 2003 and 2014. The patients were divided into early-aged (65–74 years) and late-aged (≥75 years) groups. Comorbidity was parametrized using the Charlson comorbidity index (CCI). Kaplan–Meier analysis was used to analyze overall survival (OS) and distant metastasis-free survival (DMFS). Prognostic factors were evaluated by Cox proportional hazards regression. Results: The surgical method, subtypes, stage, and oncological features were similar between early- and late-aged groups; however, smaller proportions of patients in the late-aged group received chemotherapy (12.9% vs. 45.5%) and endocrine therapy (55.3% vs. 73.3%). In multivariable analysis, the poor prognostic factors associated with DMFS and OS were high CCI, high histologic grade, and advanced stage. Chemotherapy, endocrine therapy, and radiotherapy were not significantly related to DMFS and OS. Conclusion: In this study, adjuvant treatments did not affect the prognosis of elderly patients with breast cancer. To clarify the effects of adjuvant therapies in these patients, a large-scale retrospective study that considers not only tumor characteristics but also life expectancy is necessary.
참고문헌 (30)
- "Definition of an older or elderly person" (2010)[URL]
- "2016 Statistical report on the aged"[URL]
- Kontis V, "Future life expectancy in 35 industrialised countries : projections with a bayesian model ensemble", Lancet, 389, pp.1323~1335 (2017)
- Karuturi M, "Approach and management of breast cancer in the elderly", Clin Geriatr Med, 32, pp.133~153 (2016)
- Berglund A, "Impact of comorbidity on management and mortality in women diagnosed with breast cancer", Breast Cancer Res Treat, 135, pp.281~289 (2012)
- Wallwiener CW, "Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?", J Cancer Res Clin Oncol, 142, pp.1847~1853 (2016)
- Owusu C, "Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women", Breast Cancer Res Treat, 102, pp.227~236 (2007)
- Muss HB, "Adjuvant chemotherapy in older women with early-stage breast cancer", N Engl J Med, 360, pp.2055~2065 (2009)
- Bouchardy C, "Undertreatment strongly decreases prognosis of breast cancer in elderly women", J Clin Oncol, 21, pp.3580~3587 (2003)
- Dehal A, "Comorbidity and outcomes after surgery among women with breast cancer : analysis of nationwide in-patient sample database", Breast Cancer Res Treat, 139, pp.469~476 (2013)
- Houterman S, "Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients", Br J Cancer, 90, pp.2332~2337 (2004)
- Klepin HD, "Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial : CALGB 49907 and CALGB 361004(alliance)", J Oncol Pract, 10, pp.e285~92 (2014)
- Wildes TM, "Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer", J Geriatr Oncol, 4, pp.227~234 (2013)
- Yancik R, "Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older", JAMA, 285, pp.885~892 (2001)
- Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation", J Chronic Dis, 40, pp.373~383 (1987)
- Edge SB, "The American Joint Committee on Cancer : the 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17, pp.1471~1474 (2010)
- Goldhirsch A, "Personalizing the treatment of women with early breast cancer : highlights of the st gallen international expert consensus on the primary therapy of early breast cancer 2013", Ann Oncol, 24, pp.2206~2223 (2013)
- Sesterhenn AM, "The status of neck node metastases in breast cancer-loco-regional or distant", Breast, 15, pp.181~186 (2006)
- Hurria A, "Factors influencing treatment patterns of breast cancer patients age 75 and older", Crit Rev Oncol Hematol, 46, pp.121~126 (2003)
- Yamada A, "Operation with less adjuvant therapy for elderly breast cancer", J Surg Res, 204, pp.410~417 (2016)
- Biganzoli L, "Management of elderly patients with breast cancer : updated recommendations of the International Society of Geriatric Oncology(SIOG)and European Society of Breast Cancer Specialists(EUSOMA)", Lancet Oncol, 13, pp.e148~e160 (2012)
- Bonadonna G, "Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer : the results of 20 years of follow-up", N Engl J Med, 332, pp.901~906 (1995)
- Braithwaite D, "Prognostic impact of comorbidity among long-term breast cancer survivors : results from the LACE study", Cancer Epidemiol Biomarkers Prev, 21, pp.1115~1125 (2012)
- Muss HB, "Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer", JAMA, 293, pp.1073~1081 (2005)
- Doyle JJ, "Chemotherapy and cardiotoxicity in older breast cancer patients : a population-based study", J Clin Oncol, 23, pp.8597~8605 (2005)
- Garg P, "Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients", Breast J, 15, pp.404~408 (2009)
- Lodi M, "Breast cancer in elderly women and altered clinico-pathological characteristics : a systematic review", Breast Cancer Res Treat, 166, pp.657~668 (2017)
- Early Breast Cancer Trialists’ Collaborative G, "Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials", Lancet, 365, pp.1687~1717 (2005)
- Land LH, "Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer", Br J Cancer, 107, pp.1901~1907 (2012)
- de Kruijf EM, "Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients", Mol Oncol, 8, pp.1014~1025 (2014)